The AML Prognostic Panel Cytogenetics PCR test is crucial for diagnosing acute myeloid leukemia (AML) by detecting genetic mutations.it helps guide treatment decisions and predict patient outcomes.
- Call Anytime: +254 704 150555
- info@biopassiondiagnostics.co.ke
AML Prognostic Panel Cytogenetics PCR AMLETO INV16 PMLRARA FLT3 NPM1 CEBPA
Genetic Testing
AML Prognostic Panel Cytogenetics PCR AMLETO INV16 PMLRARA FLT3 NPM1 CEBPA
KSh 56,000.00
Regular price
KSh 48,720.00
Current price
-13%
What Is the AML Prognostic Panel Cytogenetics PCR AMLETO INV16 PMLRARA FLT3 NPM1 CEBPA?
The AML Prognostic Panel Cytogenetics PCR test is a sophisticated diagnostic tool designed to evaluate genetic abnormalities associated with acute myeloid leukemia (AML). This test plays a pivotal role in the diagnosis, prognosis, and treatment planning for patients with AML, allowing healthcare providers to tailor therapies based on the specific genetic profile of the disease.
- Turnaround Time: 5-7 days
- Sample Type: Bone marrow / Peripheral blood (Transport immediately)
- Test Components: EDTA Vacutainer (3 ml)
- Pre-test Instructions: The AML Prognostic Panel (Cytogenetics + PCR) can be done with a Doctor’s prescription. Note that a prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Who Should Consider This Test?
Patients presenting with symptoms of acute myeloid leukemia such as:
- Fatigue
- Frequent infections
- Easy bruising or bleeding
- Weight loss
Individuals with risk factors, including previous chemotherapy or radiation treatment, should also consider this test. It is essential for monitoring disease progression and response to therapy.
What Does the Test Detect or Measure?
This test detects various genetic mutations and chromosomal abnormalities, including:
- AMLETO
- INV[16]
- PML/RARA
- FLT3
- NPM1
- CEBPA
By identifying these mutations, the test helps in assessing the prognosis of AML and guiding treatment decisions.
What the Results May Show
Results from the AML Prognostic Panel Cytogenetics PCR test will indicate the presence or absence of specific genetic mutations. Your healthcare provider will explain the implications of these results and how they impact your treatment plan. It is crucial to have a thorough discussion with your doctor regarding your findings.
Benefits or Clinical Value
Taking the AML Prognostic Panel Cytogenetics PCR test offers numerous benefits:
- Accurate diagnosis of AML
- Identification of specific genetic mutations that may influence treatment options
- Prognostic information to help predict disease outcomes
- Guidance for personalized treatment plans
Pricing
| Test Name | Current Price | Regular Price |
|---|---|---|
| AML Prognostic Panel Cytogenetics PCR AMLETO INV16 PMLRARA FLT3 NPM1 CEBPA | KSh 48,720.00 | KSh 56,000.00 |
Book the AML Prognostic Panel Cytogenetics PCR AMLETO INV16 PMLRARA FLT3 NPM1 CEBPA
Contact Biopassion Diagnostics to confirm sample requirements and schedule this test.
SKU: ac2a728f9f17 | Category: Genetic Testing